Case Study: NMPA-FDA Concurrent Review Successes in Global Trials
Practical lessons from sponsors and data managers on NMPA-FDA concurrent reviews, CTIS-ready oncology dossiers, operational RWE, and compliant psilocybin protocols—clear steps, survey insights, and patient rights to guide global trials.
Robert Maxwell
Oct 08, 2025
Breast cancer approvals
stroke trial compliance
GLP-1 regulatory pathway
Psilocybin research oversight